Main menu button

News

Research Update InCoax, Q2 2021: Good order intake and gross margin in Q2
24 aug 2021
Research Update InCoax, Q2 2021: Good order intake and gross margin in Q2
Equity Research InCoax
First Impression InCoax, Q2 2021: Good order intake and gross margin bodes well
20 aug 2021
First Impression InCoax, Q2 2021: Good order intake and gross margin bodes well
Equity Research InCoax
Investment case Modus Therapeutics: Significant potential with proven technology
07 jul 2021
Investment case Modus Therapeutics: Significant potential with proven technology
Equity Research Modus Therapeutics
Equity Research, DanCann Pharma Q1 2021: Good news flow increases fair value
03 jun 2021
Equity Research, DanCann Pharma Q1 2021: Good news flow increases fair value
Equity Research
Research Update InCoax Networks Q1 2021: Higher revenues plus orders bode well
21 maj 2021
Research Update InCoax Networks Q1 2021: Higher revenues plus orders bode well
Equity Research InCoax
Mrkt BUZZ Arctic Minerals: Record high copper price implies potential
20 maj 2021
Mrkt BUZZ Arctic Minerals: Record high copper price implies potential
Equity Research Arctic Minerals
The next generation of biopsy instruments
27 apr 2021
The next generation of biopsy instruments
Equity Research
Investment Case All for One Group: The SAP S4/HANA conversion to last until 2027
26 apr 2021
Investment Case All for One Group: The SAP S4/HANA conversion to last until 2027
Equity Research All for One Group
Initial Coverage InCoax Networks: The start of a breakthrough in the US
15 apr 2021
Initial Coverage InCoax Networks: The start of a breakthrough in the US
Equity Research InCoax
The market is resembling the 1999 rally- focus on SPAC and crypto
16 feb 2021
The market is resembling the 1999 rally- focus on SPAC and crypto
Equity Research
Investment Case Frequentis: Stable growth in high-security business
26 jan 2021
Investment Case Frequentis: Stable growth in high-security business
Equity Research Frequentis
Analysis Kancera: Capital raised for phase II
17 mar 2020
Analysis Kancera: Capital raised for phase II
Equity Research
Analysis Cantargia: targeted share issue - a sign of strength
10 mar 2020
Analysis Cantargia: targeted share issue - a sign of strength
Equity Research
Analysis Adventure Box: Good potential at high risk
10 mar 2020
Analysis Adventure Box: Good potential at high risk
Equity Research
Analysis Amasten: Exciting corner in SSM
09 mar 2020
Analysis Amasten: Exciting corner in SSM
Equity Research
Analysis Flowscape: International expansion
05 mar 2020
Analysis Flowscape: International expansion
Equity Research
Analysis Bonesupport: Continued Growth
05 mar 2020
Analysis Bonesupport: Continued Growth
Equity Research
Analysis Ascelia Pharma: Phase III with Mangoral
05 mar 2020
Analysis Ascelia Pharma: Phase III with Mangoral
Equity Research
Analysis Soltech: Strong growth but the Corona virus is a short term threat
02 mar 2020
Analysis Soltech: Strong growth but the Corona virus is a short term threat
Equity Research
Analysis Raytelligence: Broadens sales to several sectors
28 feb 2020
Analysis Raytelligence: Broadens sales to several sectors
Equity Research